Dr Ecaterina Dumbrava speaks to ecancer online about the trial of COM701as a monotherapy and in combination with nivolumab which was presented that the AACR 2020 virtual meeting.

Dr Dumbrava outlines the trial design, including the monotherapy and combination (with nivolumab) arms.

She provides overall data, and also specific patient examples, which looks very promising especially considering the low level of toxicity.